GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Arvee Laboratories (India) Ltd (NSE:ARVEE) » Definitions » Capex-to-Revenue

Arvee Laboratories (India) (NSE:ARVEE) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Arvee Laboratories (India) Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Arvee Laboratories (India)'s Capital Expenditure for the three months ended in Mar. 2024 was ₹0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹61.44 Mil.

Hence, Arvee Laboratories (India)'s Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


Arvee Laboratories (India) Capex-to-Revenue Historical Data

The historical data trend for Arvee Laboratories (India)'s Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arvee Laboratories (India) Capex-to-Revenue Chart

Arvee Laboratories (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.06 0.02 0.09

Arvee Laboratories (India) Quarterly Data
Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Arvee Laboratories (India)'s Capex-to-Revenue

For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvee Laboratories (India)'s Capex-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Arvee Laboratories (India)'s Capex-to-Revenue falls into.



Arvee Laboratories (India) Capex-to-Revenue Calculation

Arvee Laboratories (India)'s Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-25.859) / 303.452
=0.09

Arvee Laboratories (India)'s Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 61.435
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arvee Laboratories (India)  (NSE:ARVEE) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Arvee Laboratories (India) Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arvee Laboratories (India)'s Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Arvee Laboratories (India) (NSE:ARVEE) Business Description

Traded in Other Exchanges
N/A
Address
403, Iskcon Bopal Road, Entice, Near Jayantilal Park BRTS, Ambli, Ahmedabad, GJ, IND, 380058
Arvee Laboratories (India) Ltd is an India based specialty chemicals company. The company products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.

Arvee Laboratories (India) (NSE:ARVEE) Headlines

No Headlines